Antibody response to mRNA SARS-CoV-2 vaccines in haemodialysis patients.

Michael PaalFlorian M ArendTobias LauSandra HasmannDaniela Soreth-RiekeJohanna Sorodoc-OttoWilke BeuthienJulia KrappeMarcell ToepferGero von GersdorffNorbert ThallerSimon RauBernd H NorthoffDaniel TeupserMathias BruegelMichael FischerederUlf Schönermarck

Published in: Clinical kidney journal (2021)

We strongly argue in favour of regular antibody testing after COVID-19 vaccination in haemodialysis patients. Further studies should elucidate the utility of booster vaccinations to foster a stronger and persistent antibody response.

Keyphrases

end stage renal disease
sars cov
chronic kidney disease
peritoneal dialysis
newly diagnosed
ejection fraction
prognostic factors
respiratory syndrome coronavirus